Home Healthcare THE WORLD MOVES TOWARDS DEFEATING COVID-19 172 COUNTRIES & MULTIPLE CANDIDATE VACCINES...

THE WORLD MOVES TOWARDS DEFEATING COVID-19 172 COUNTRIES & MULTIPLE CANDIDATE VACCINES ENGAGED IN COVID-19 VACCINE GLOBAL ACCESS FACILITY

321
0
SHARE

Spread the love

WHO issues advisory on the use of masks for children in the community in the context of COVID- The World Health Organisation has in conjunction with UNICEF issued a statement on  the use of masks for children in the community in the context of COVID-19 just as it has announced progress report on vaccines.  Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coordinated COVAX Facility, joining 92 low- and middle-income economies that are eligible to be supported by the COVAX Advance Market Commitment (AMC) Goal of bringing the pandemic under control via equitable access to COVID-19 vaccines needs urgent, broadscale commitment and investment from countries The World Health Organisation announced that 172 economies are now engaged in discussions to potentially participate in COVAX, a global initiative aimed at working with vaccine manufacturers to provide countries worldwide equitable access to safe and effective vaccines, once they are licensed and approved. COVAX currently has the world’s largest and most diverse COVID-19 vaccine portfolio – including nine candidate vaccines, with a further nine under evaluation and conversations underway with other major producers.   A WHO statement released in Genveva today states that: COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries. In order to be able to secure enough doses of vaccines to protect the most vulnerable populations, such as health workers and the elderly, the next step for the partnership is to confirm potential self-financing participants’ intent to participate by 31 August and to turn these into binding commitments to join the COVID-19 Vaccine Global Access Facility (COVAX Facility) by September 18th, with first upfront payments to follow thereafter, and no later than October 9th. “Equal access to a COVID-19 vaccine is the key to beating the virus and paving…

This content is for 1 Month Subscription and Unlimited Access members only.
Login Join Now